Ann Arbor, Michigan
CNS clinical trials in Ann Arbor, MI
47 CNS studies are recruiting participants at sites in Ann Arbor as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Ann Arbor at a glance
- 47 studies are recruiting at a site in Ann Arbor.
- By phase: Phase 1 (2), Phase 1/2 (5), Phase 2 (11), Phase 3 (12), Phase 4 (2), No phase (10), Observational (5). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (26), university, hospital or other (20), government (1).
- By research area: Depression (13), Migraine (11), Parkinson's Disease (10), Epilepsy (7), Multiple Sclerosis (4), Bipolar Disorder (1), Schizophrenia (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Ann Arbor
Basic details from each study's public record (the 30 most recently updated of 47). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- University of Michigan
- Registry record
- NCT07002034 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study site
- Michigan Clinical Research Institute PC
- Registry record
- NCT03887715 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Study site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
- Registry record
- NCT06748222 · updated
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT07553637 · updated
ALTO-100 in Bipolar Disorder With Depression (BD-D)
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT06656416 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Ann Arbor, MI on ClinicalTrials.gov.
Schizophrenia studies recruiting in Ann Arbor
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT07459647 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Ann Arbor, MI on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Ann Arbor
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments
- Phase 1/2
- Ages 45 and older
- All sexes
- Sponsor
- Prabesh Kanel
- Study site
- Domino's Farms
- Registry record
- NCT07154511 · updated
Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation
- Observational
- Ages 45 and older
- All sexes
- Sponsor
- University of Michigan
- Study site
- University of Michigan
- Registry record
- NCT07642908 · updated
Tributyrin for Progressive Supranuclear Palsy (PSP): Virtual Trial
- Phase 1/2
- Ages 45 and older
- All sexes
- Sponsor
- Prabesh Kanel
- Study site
- Domino's Farms
- Registry record
- NCT07863180 · updated
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- Phase 3
- Ages 45 to 75
- All sexes
- Sponsor
- BlueRock Therapeutics
- Study sites
- Michigan Clinical Research Unit - Neurology · University of Michigan Clinical Research Unit - Neurology
- Registry record
- NCT06944522 · updated
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Phase 2
- Ages 30 to 80
- All sexes
- Sponsor
- Appello Pharmaceuticals, Inc.
- Study site
- University of Michigan Health System (UMHS) (Site #202)
- Registry record
- NCT07432958 · updated
A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease
- Phase 1
- Ages 50 and older
- All sexes
- Sponsor
- University of Michigan
- Study site
- Domino's Farms
- Registry record
- NCT07543861 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Ann Arbor, MI on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Ann Arbor
A Study of AZD0120 in Autoimmune Diseases
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT07295847 · updated
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06433752 · updated
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06680037 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Ann Arbor, MI on ClinicalTrials.gov.
Epilepsy studies recruiting in Ann Arbor
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- University of Michigan Hospitals
- Registry record
- NCT05667142 · updated
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
- Phase 1/2
- Ages 2 to 12
- All sexes
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Study site
- University of Michigan Health System
- Registry record
- NCT07531745 · updated
Diagnosing Epilepsy To EffeCT Change
- No phase
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Michigan Medicine
- Registry record
- NCT07110337 · updated
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Study site
- Mott Children's Hospital
- Registry record
- NCT05419492 · updated
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Observational
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- Michigan Medicine
- Registry record
- NCT07110454 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Ann Arbor, MI on ClinicalTrials.gov.
Migraine studies recruiting in Ann Arbor
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- Michigan Headache and Neurological Institute
- Registry record
- NCT07616128 · updated
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Michigan Headache Pain & Neurological Institute
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Michigan Headache Pain & Neurological Institute
- Registry record
- NCT07674654 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Michigan Head Pain & Neurological Institute
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Michigan Head Pain and Neurological Institute
- Registry record
- NCT04743141 · updated
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Michigan Headache & Neurological Institute
- Registry record
- NCT07609914 · updated
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- Michigan Headache & Neurological Institute
- Registry record
- NCT07729462 · updated
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Michigan Headache & Neurological Institute /ID# 270942
- Registry record
- NCT06810505 · updated
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Michigan Headache & Neurological Institute (MHNI) /ID# 247468
- Registry record
- NCT05711394 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Ann Arbor, MI on ClinicalTrials.gov.
Ask about studies near Ann Arbor
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections